Fig. 3From: Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic responseResponse of orthotopic B4B8 murine HNSCC tumors to AZD8931. B4B8 cells were inoculated into the buccal space of BALB/c mice as described in the Materials and Methods. When tumors reached 40 to 50 mm3 (~ 15 to 16 days after inoculation), mice were randomized for daily gavage with diluent or 50 m/kg AZD8931. Tumor diameter was measured with calipers and volume was calculated as described. a Time course of growth of buccal B4B8 tumors treated daily by oral gavage with diluent control (n = 50) or 50 mg/kg AZD8931 (n = 53). The data are the mean and SEM of three independent compiled experiments. b The therapeutic responses of individual B4B8 tumors after 7 days of diluent or AZD8931 treatment are presented as the percent change from initial tumor volumeBack to article page